Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome

This study has been terminated.

(Unable to recruit sufficient number of participants)

Sponsor:

Collaborators:

Rare Diseases Clinical Research Network

Information provided by (Responsible Party):

Robert Griggs, MD, University of Rochester

ClinicalTrials.gov Identifier:

NCT00839501

First received: February 5, 2009

Last updated: January 19, 2012

Last verified: January 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	January 2011
Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)